sepimostate mesilate has been researched along with lisinopril in 1 studies
Studies (sepimostate mesilate) | Trials (sepimostate mesilate) | Recent Studies (post-2010) (sepimostate mesilate) | Studies (lisinopril) | Trials (lisinopril) | Recent Studies (post-2010) (lisinopril) |
---|---|---|---|---|---|
27 | 4 | 1 | 2,210 | 648 | 491 |
Protein | Taxonomy | sepimostate mesilate (IC50) | lisinopril (IC50) |
---|---|---|---|
Angiotensin-converting enzyme | Homo sapiens (human) | 0.0021 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.287 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0012 | |
Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.0012 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbenante, G; Fairlie, DP; Leung, D | 1 |
1 review(s) available for sepimostate mesilate and lisinopril
Article | Year |
---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |